The US Food and Drug Administration has approved nivolumab (Opdivo) for the adjuvant treatment of urothelial carcinoma (UC) in cases in which there is a high risk for recurrence following radical resection, according to an announcement from its maker, Bristol-Meyers Squibb (BMS). The new indication builds on the PD-1 inhibitor’s prior approvals for advanced or […]
Home »
Study explores long-term outcomes and costs of non-muscle invasive bladder cancer
A new research study leveraging a database from the largest equal access health system in the US, the Department of Veteran Affairs, offers insight into the outcome of specific treatment patterns for advanced bladder cancer patients. Lead author Dr. Stephen Williams of the University of Texas Medical Branch says it is one of the first […]
Bladder cancer remains unnoticed for a long time – three signs you should take seriously
In everyday life, many toxins get into our body through air, cigarette smoke or our food. On their way through the body of the harmful substances pass through the urinary tract, through which they are finally excreted. There they can cause cancer. Many do have pain in the water as harmless bubbles of inflammation. In […]